Toralizumab (IDEC 131) was a humanized monoclonal antibody and an immunosuppressive drug. Possible indications included treatment of antibody-mediated...
3 KB (188 words) - 00:48, 14 May 2023
Oxelumab Ruplizumab Tabalumab Tavolixizumab Teneliximab Tigatuzumab Toralizumab Urelumab Utomilumab Varlilumab Vorsetuzumab Vorsetuzumab mafodotin Decoy...
49 KB (6,233 words) - 07:30, 6 November 2024
Rituximab Ublituximab CD23 Gomiliximab Lumiliximab CD40 Teneliximab Toralizumab CD62L/L-selectin Aselizumab CD80 Galiximab CD147/Basigin Gavilimomab...
7 KB (299 words) - 13:45, 27 April 2024
Democratic Education Conference, an annual academic and youth conference Toralizumab (IDEC 131), an antibody and an immunosuppressive drug The sponsor name...
591 bytes (108 words) - 17:53, 28 May 2021
Oxelumab Ruplizumab Tabalumab Tavolixizumab Teneliximab Tigatuzumab Toralizumab Urelumab Utomilumab Varlilumab Vorsetuzumab Vorsetuzumab mafodotin Decoy...
5 KB (305 words) - 05:22, 23 October 2024
Spartalizumab† Talizumab Teclistamab Teplizumab Tislelizumab Tocilizumab Toralizumab Tregalizumab Vatelizumab Vedolizumab Visilizumab Vobarilizumab TGN1412§...
38 KB (4,316 words) - 10:24, 26 August 2024
(INN) Toprol-XL Topsyn topterone (INN) toquizine (INN) Tora Toradol toralizumab (USAN) torapsel (USAN) torasemide (INN) torbafylline (INN) torcetrapib...
7 KB (373 words) - 02:05, 25 April 2024
Tomuzotuximab mab humanized Epidermal growth factor receptor (EGFR), HER1 cancer Toralizumab mab humanized CD154 (CD40L) rheumatoid arthritis, lupus nephritis etc...
137 KB (4,083 words) - 21:25, 19 October 2024
Oxelumab Ruplizumab Tabalumab Tavolixizumab Teneliximab Tigatuzumab Toralizumab Urelumab Utomilumab Varlilumab Vorsetuzumab Vorsetuzumab mafodotin Decoy...
8 KB (316 words) - 13:53, 10 September 2024
Oxelumab Ruplizumab Tabalumab Tavolixizumab Teneliximab Tigatuzumab Toralizumab Urelumab Utomilumab Varlilumab Vorsetuzumab Vorsetuzumab mafodotin Decoy...
8 KB (501 words) - 13:55, 10 September 2024